Want to join the conversation?
Technology solutions integrator $PLUS' full year FY16 net sales grew 5.3%, led by rise in Technology segment revenue. FY16 adjusted gross billings of products and services grew 8.5%. 4Q16 net sales grew 12% due to some orders that were in transit at close of 3Q16, while adjusted gross billings of products and services grew 17.4%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?